Trial NCT03827473

View at ClinicalTrials.gov 
Org. Study IDs: HCI115099

Last trial update was posted on 2020-06-25

MeSH Interventions

Abiraterone Acetate Androgen Antagonists Androgens Ascorbic Acid Cortisone Docetaxel Estrogens, Conjugated (USP) Hormones Methyltestosterone Prednisone

MeSH Conditions

Hypersensitivity Prostatic Neoplasms

Other Conditions

Castration-Sensitive Prostate Carcinoma Metastatic Prostatic Adenocarcinoma Stage IV Prostate Cancer Stage IVA Prostate Cancer Stage IVB Prostate Cancer

Stopping Reasons

The trial was closed because the changing standard of care landscape, making this trial not impactful anymore.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID